Pyridostigmine blunts the increases in myocardial oxygen demand elicited by the stimulation of the central nervous system in anesthetized rats

Clinical Autonomic Research

Volumn 9, Issue 2, 1999, Pages 83-89

  Grabe Guimarães, Andrea ^a,b   Alves, Leandro M ^a   Tibiriçá, Eduardo ^a   Nóbrega, Antonio C L ^c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Acetylcholine; Autonomic nervous system; Central nervous system; L glutamate; Myocardial oxygen demand; Pyridostigmine bromide

Indexed keywords

ACETYLCHOLINE; CHOLINESTERASE; GLUTAMIC ACID; PENTOBARBITAL; PYRIDOSTIGMINE;

ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; ENZYME ACTIVITY; EXERCISE; HEART MUSCLE OXYGEN CONSUMPTION; HEART PROTECTION; HEART WORK; ISCHEMIC HEART DISEASE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; STRESS;

ANESTHESIA; ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; CENTRAL NERVOUS SYSTEM STIMULANTS; CHOLINESTERASE INHIBITORS; CHOLINESTERASES; EXCITATORY AMINO ACID AGONISTS; GLUTAMIC ACID; INJECTIONS, INTRAVENTRICULAR; MALE; MYOCARDIUM; OXYGEN CONSUMPTION; PYRIDOSTIGMINE BROMIDE; RATS; RATS, WISTAR;

EID: 0032851831     PISSN: 09599851     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02311764     Document Type: Article

References (42)

1. Bilman GE, Schwartz PJ, Tone HL. Baroreceptor reflex control of heart rate: A predictor of sudden cardiac death. Circulation 1984; 66:874-881.
2. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 1992; 85(Suppl 1):177-199.
3. Odemuyiwa O, Malik M, Farrell T, Bashir Y, Poloniecki J, Camm J. Comparision of the predictive characteristics of the heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction. Am J Cardiol 1991; 68:434-439.
4. La Rovere MT, Bigger JTJr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998; 351:478-484.
5. Eliakim M, Bellet S, Tawil E, Muller O. Effect of vagal stimulation and acetylcholine on the ventricle: Studies in dogs with complete heart block. Circ Res 1961; 9:1372-1379.
6. Waxman MB, Cupps CL, Cameron DA. Modulation of an idioventricular rhythm by vagal tone. J Am Coll Cardiol 1988; 11:1052-1060.
7. Schwartz PJ, Verrier RL, Lown B. Effect of stellectomy and vagotomy on ventricular refractoriness. Circ Res 1977; 40:536-540.
8. Martins JB, Zipes DP. Effects of sympathetic and vagal nerves on recovery properties of the endocardium and epicardium of the canine left ventricle. Circ Res 1980; 46:100-110.
9. De Ferrari GM, Salvati P, Grossoni M, et al. Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacoline and oxotremorine in conscious dogs with a healed myocardial infarction. J Am Coll Cardiol 1993; 21:283-290.
10. Hollenberg M, Carriere S, Barger AC. Biphasic action of acetylcholine on ventricular myocardium. Circ Res 1965; 16:527-536.
11. Levy MN, Zieske H. Comparision of the cardiac effects of vagus nerve stimulation and acetylcholine infusions. Am J Physiol 1969; 216:890-897.
12. Higgins CB, Vatner SF, Braunwald E. Parasympathetic control of the heart. Pharmacol Rev 1973; 25:119-155.
13. Löffelholz K, Pappano AJ. The parasympathetic neuroeffector junction of the heart. Pharmacol Rev 1985; 37:1-24.
14. Tibiriçá E, Monassier L, Feldman J, Brandt C, Verdun A, Bousquet P. Baclofen prevents the increase of myocardial oxygen demand indexes evoked by the hypothalamic stimulation in rabbits. Naunyn Schmiedeberg's Arch Pharmacol 1993; 348:164-171.
15. B agonist. Br J Pharmacol 1995; 115:1331-1335.
16. Magnotti Jr RA, Eberly JP, Quarm DE and McConnell RS. Measurement of acetylcholinesterase in erythrocytes in the field. Clin Chem 1987; 33:1731-1735.
17. Azevedo AD, Hilton SM, Timms RJ. The defence reaction elicited by midbrain and hypothalamic stimulation in the rabbit. J Physiol London 1980; 301:56P-57P.
18. Resnik H, Mason MF. The effect of the injection of certain nitrogen-containing compounds into the cisterna magna on the blood pressure of dogs. Am J Med Sci 1936; XX:520-525.
19. Lown B, Verrier RL, Rabinowitz SH. Neural and psychologic mechanisms and the problem of sudden cardiac death. Am J Cardiol 1977; 39:890-972.
20. Reich P, Da Silva DA, Lown B, Murawski J. Acute psychological disturbance preceeding life-threatening ventricular arrhythmias. JAMA 1981; 246:233-235.
21. Specchia G, De Servi S, Falcone C, et al. Mental arithmetic stress testing in patients with coronary artery disease. Am Heart J 1984; 108:56-63.
22. Monassier L, Tibiriçá E, Roegel JC, Mettauer B, Feldman J, Bousquet P. Prevention by NMDA receptor antagonists of the centrallyevoked increases of cardiac inotropic responses in rabbits. Br J Pharmacol 1994; 111:1347-1354.
23. Taylor P. Anticholinesterase agents. In: Hardman JG and Limbird LE (Editors-in-Chief). Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill; 1996:161-176.
24. Tseng CJ, Appalsamy M, Robertson D, Mosqueda-Garcia. Effects of nicotine on brain stem mechanisms of cardiovascular control. J Pharmacol Exp Ther 1993, 265:1511-1518.
25. Nóbrega ACL, Carvalho ACG, Bastos BG. Resting and reflex heart rate responses during cholinergic stimulation with pyridostigmine in humans. Braz J Med Biol Res 1996; 29:1461-1465.
26. Stephenson LA, Kolka MA. Acetylcholinesterase inhibitor, pyridostigmi ne bromide, reduces skin blood flow in humans. Am J Physiol 1990; 258 (4 Pt 2):R951-R957.
27. Reis AF, Moraes RS, Bastos BG, Ferlin E, Ribeiro JP, Nóbrega ACL. Heart rate variability during cholinergic stimulation with pyridostigmine in healthy subjects. J Am Coll Cardiol 1998; 31:407C.
28. Izraeli S, Alcalay M, Benjamini Y, Wallach-Kapon R, Tochner Z, Akselrod S. Modulation of the dose-dependent effects of atropine by low-dose pyridostigmine: Quantification by spectral analysis of heart rate fluctuations in healthy human beings. Pharmacol Biochem Behav 1991; 39:613-617.
29. Pontes PV, Bastos BG, Mesquita ET, Nóbrega ACL. Cholinergic stimulation with pyridostigmine: Echocardiographic analysis in healthy subjects. J Am Coll Cardiol 1998; 31:433C.
30. Thaulow E, Erikssen JE. How important is heart rate? J Hypertension 1991; 9(suppl.):S27-S30.
31. Nóbrega ACL, Carvalho ACG, Santos KB, Soares PPS. Cholinergic stimulation with pyridostigmine blunts the cardiac reponses to mental stress. Clin Auton Res 1999; 9:11-16.
32. Löffelholz K, Muscholl E. Inhibition by parasympathetic nerve stimulation of the release of the adrenergic transmitter. Naunyn Schmiedeberg's Arch Pharmacol 1970; 267:181-184.
33. Yang ZK, Boyett MR, Janvier SO, McMorn SO, Shui Z, Karim F. Regional differences in the negative inotropic effect of acetylcholine within the canine ventricle. J Physiol 1996; 492(3):789-806.
34. Levy MN, Blattberg B. Effect of vagal stimulation on the overflow of norepinephrine into the coronary sinus during cardiac sympathetic nerve stimulation in the dog. Circ Res 1976; 38:81-85.
35. Muscholl E. Peripheral muscarinic control of norepinephrine release in the cardiovascular system. Am J Physiol 1980; 239:H713-H720.
36. Koumi SI, Sato R, Nagasawa K, Hayakawa H. Activation of inwardly rectifying channels by muscarinic receptor-linked G protein in isolated human ventricular myocytes. J Membrane Biol 1997; 157:71-81.
37. Gao J, Mathias RT, Cohen IS, Baldo GJ. Effects of acetylcholine on the Na -K pump corrent in guinea-pig ventricular myocytes. J Physiol 1997; 501(3):527-535.
38. Bailey JC, Greenspan K, Elizari MV, Anderson GJ, Fisch C. Effects os acetylcholine on automaticity and conduction in the proximal portion of the His-Purkinje specialized conduction system of the dog. Circ Res 1972; 30:210-216.
39. Bailey JC, Watanabe AM, Besch HRJr, Lathrop DA. Acetylcholine antagonism of the electrophysiological effects of isoproterenol on canine cardiac Purkinje fibers. Circ Res 1979; 44:378-383.
40. Litovsky SH, Antzelevitch C. Differences in the electrophysiological response of canine ventricular subendocardium and subepicardium to acetylcholine and isoproterenol. A direct effect of acetylcholine in ventricular myocardium. Circ Res 1990; 67:615-627.
41. Kent KM, Smith ER, Redwood DR, Epstein SE. Electrical stability of acutely ischemic myocardium: Influences of heart rate and vagal stimulation. Circulation 1973; 47:291-298.
42. Waxman MB, Wald RW. Termination of ventricular tachycardia by increase in cardiac vagal drive. Circulation 1977; 56:385-391.